Flagship Pioneering related stories
All articles and analysis
Laronde nets $50mLaronde, an eRNA company, has raised $50 million in funding.
- Repertoire Immune Medicines inks $189m Series B
Repertoire Immune Medicines, a clinical-stage biotech company, has secured $189 million in Series B financing.
Valo Health closes $190m Series B led by PSP InvestmentsBoston-based Valo Health, a technology company that uses human-centric data and machine learning for drug discovery and development, has closed a $190 million Series B financing.
Rising Stars 2021For the second year in a row, we reached out to readers and others in the venture capital community to find out who are the industry’s up and comers. It was a difficult task, but we crafted a list of 40 professionals under 40 who are certain to shape VC as the next generation of rising stars.
- VC-backed Foghorn Therapeutics goes public
Cambridge, Massachusetts-based Foghorn Therapeutics, a developer of therapies for cancer and other serious diseases, has raised about $120 million for its IPO after pricing its 7.5 million shares at $16 per share.
- VC-backed Codiak Biosciences goes public
Codiak Biosciences Inc, a developer of exosome-based therapeutics, has raised about $82.5 million for its IPO after pricing its 5.5 million shares at $15 per share.
- Indigo Ag racks up $360m
Boston-based Indigo Agriculture Inc, which is focused on "harnessing nature to help farmers sustainably feed the planet," has raised $360 million in funding.
- Omega Therapeutics amasses $85m
Cambridge, Massachusetts-based Omega Therapeutics, a genomic medicine company, has raised $85 million in financing.
- Sana Biotechnology picks up $700m in VC financing
Sana Biotechnology, a Seattle, Washington-based company focused on creating and delivering engineered cells as medicines, has raised more than US$700 million.
Michigan pension bets big on ventureThe State of Michigan Retirement Systems committed $335 million to five funds in the first quarter of 2020.